MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$17,964K
EPS
-$0.43
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
13,844
15,166
14,988*
13,648
General and administrative
4,824
4,736
5,365*
6,039
Total operating expenses
18,668
19,902
20,353
19,687
Loss from operations
-18,668
-19,902
-20,353*
-19,687
Interest income
860
989
1,625*
1,506
Other expense, net
-156
-129
-60*
-53
Total other income, net
704
860
1,565*
1,453
Net loss
-17,964
-19,042
-18,788
-18,234
Unrealized gain (loss) on available-for-sale investments, net of tax
-
-
-
6
Comprehensive loss
-
-
-
-18,228
Basic EPS
-0.43
-0.49
-0.488
-0.47
Diluted EPS
-0.43
-0.49
-0.488
-0.47
Basic Average Shares
41,841,887
38,724,803
38,505,760
38,560,464
Diluted Average Shares
41,841,887
38,724,803
38,505,760
38,560,464
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income
$860K
(-50.29%↓ Y/Y)
Net loss
-$17,964K
(14.48%↑ Y/Y)
Total other income,
net
$704K
(-57.15%↓ Y/Y)
Other expense, net
-$156K
(-79.31%↓ Y/Y)
Loss from operations
-$18,668K
(17.58%↑ Y/Y)
Total operating
expenses
$18,668K
(-17.58%↓ Y/Y)
Research and development
$13,844K
(-14.45%↓ Y/Y)
General and
administrative
$4,824K
(-25.41%↓ Y/Y)
Buy us a coffee
Acrivon Therapeutics, Inc. (ACRV)
Acrivon Therapeutics, Inc. (ACRV)